Literature DB >> 12664060

Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines.

M M Daja1, X Niu, Z Zhao, J M Brown, P J Russell.   

Abstract

Stromal expression of some matrix metalloproteinases (MMPs) has been associated with increasing tumour burden in prostate cancer. We investigated the expression of mRNA (by RT-PCR) and protein (by zymography and western blotting) of MMPs and endogenous inhibitors (tissue inhibitors of metalloproteinases, TIMPs) in two parent epithelial prostate cancer cell lines and sublines of increasing invasive/metastatic potential. Expression of membrane type MMPs, MT1-MMP and MT3-MMP mRNA was higher in PC3-derived than in LNCaP-derived lines, whereas MT2-MMP mRNA expression was higher in the LNCaPderived than in PC3-derived cell lines. Active MT1, MT2 and MT3-MMP protein levels were similar in all lines, but processed MT-MMPs, indicative of latent MMP activation, were increased in more aggressive sublines. Expression of MMP-1, MMP-13 and TIMP-1 was higher in the more aggressive sublines and may be implicated in invasive/metastatic ability. Regulation of MMP-1 and MMP-13 expression may offer important therapeutic options for treating patients with prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12664060     DOI: 10.1038/sj.pcan.4500609

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  18 in total

1.  Characteristics of a human prostate stromal cell line related to its use in a stromal-epithelial coculture model for the study of cancer chemoprevention.

Authors:  Lena Diaw; Mark Roth; Debra A Schwinn; Mary E d'Alelio; Lisa J Green; Joseph A Tangrea
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 May-Jun       Impact factor: 2.416

2.  Membranous type matrix metalloproteinase 16 induces human prostate cancer metastasis.

Authors:  Chunwa Jiang; Juanjing Wang; Chen Dong; Wei Wei; Jiang Li; Xiaomeng Li
Journal:  Oncol Lett       Date:  2017-07-07       Impact factor: 2.967

3.  Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer?

Authors:  Silvan Boxler; Valentin Djonov; Thomas M Kessler; Ruslan Hlushchuk; Lucas M Bachmann; Ulrike Held; Regula Markwalder; George N Thalmann
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

4.  High-content adhesion assay to address limited cell samples.

Authors:  Jay W Warrick; Edmond W K Young; Eric G Schmuck; Kurt W Saupe; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2013-02-21       Impact factor: 2.192

5.  The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression.

Authors:  Eric Guenzi; Kristin Töpolt; Clara Lubeseder-Martellato; Anita Jörg; Elisabeth Naschberger; Roberto Benelli; Adriana Albini; Michael Stürzl
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

6.  Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner.

Authors:  Sanaa M Nabha; Emanuel Burck dos Santos; Hamilto A Yamamoto; Abdelfettah Belizi; Zhong Dong; Hong Meng; Allen Saliganan; Aaron Sabbota; R Daniel Bonfil; Michael L Cher
Journal:  Int J Cancer       Date:  2008-06-01       Impact factor: 7.396

7.  Postnatal tendon growth and remodeling require platelet-derived growth factor receptor signaling.

Authors:  Kristoffer B Sugg; James F Markworth; Nathaniel P Disser; Andrew M Rizzi; Jeffrey R Talarek; Dylan C Sarver; Susan V Brooks; Christopher L Mendias
Journal:  Am J Physiol Cell Physiol       Date:  2017-12-13       Impact factor: 4.249

8.  LIM kinase1 modulates function of membrane type matrix metalloproteinase 1: implication in invasion of prostate cancer cells.

Authors:  Tenekua Tapia; Richard Ottman; Ratna Chakrabarti
Journal:  Mol Cancer       Date:  2011-01-10       Impact factor: 27.401

9.  The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.

Authors:  Yong Jae Shin; Jeong-Ho Kim
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

10.  Study of matrix metalloproteinases and their inhibitors in prostate cancer.

Authors:  S Escaff; J M Fernández; L O González; A Suárez; S González-Reyes; J M González; F J Vizoso
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.